Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
US OPEN: Falling oil prices drive risk appetite up! Nasdaq leads rebound (25.08.2026)
Market Wrap: Cautious rebound in Europe after the drop in oil prices
Nvidia Goes to Space. SpaceX Is Building Satellites Powered by Its Chips
Morning Wrap: Strong Crypto, Weaker Nasdaq and Another Chapter in the US–Canada Trade War